As af Klint’s fame has grown, so have the questions—about what she believed, whom she worked with, and who should be allowed ...

A ruling in favour of the Trump administration could result in the president exercising “unusual” control over “routine” ...

Moderna's John Ward argues that the future of in-house trademark practice will belong to the teams that have the courage to ...

Revaccination with mRNA-1345 against RSV at 12 months was noninferior to primary vaccination among adults aged 50 years and older.

The Pharma Industry Is in a Bind. President Donald Trump’s allies are resurfacing a proposal from the first Trump administration that would dramatically cut U.S. drug prices. Nvidia stock rises after ...

Read more from STAT’s Chelsea Cirruzzo and Daniel Payne for more details on what Vance had to say and what attendees received ...

Moderna stock has reached day 5 of a consecutive winning streak, with total gains during this time reaching a 13% return.

Strong financial position with cash, cash equivalents and marketable securities of $93.7M Moderna litigation U.S. trial scheduled for March ...

Roivant Sciences Ltd.'s innovative model and breakthrough autoimmune drug pipeline make it a strong buy. Click here to read ...

In this week's STATus Report, STAT reporters Jason Mast and Damian Garde discuss the challenges facing Moderna — and what could be in store for its third act.